Announcements Trials

Browse Landscape

Sponsor

Conditions

Neoplasms 9 Ovarian Neoplasms 5 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Multiple Myeloma 2 Stomach Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Digestive System Neoplasms 1 Colorectal Neoplasms 1 Bites and Stings 1 Adenocarcinoma 1

Interventions

Temozolomide 115 Bevacizumab 72 Radiotherapy 52 Radiation 23 Erlotinib Hydrochloride 13 Lomustine 12 pembrolizumab 11 Magnetic Resonance Spectroscopy 11 Vorinostat 10 Nivolumab 10 Surgical Procedures, Operative 9 Irinotecan 9 Sorafenib 8 Radiotherapy, Intensity-Modulated 8 Radiotherapy, Conformal 7 Immunoglobulin G 7 Everolimus 7 Drug Therapy 7 Disulfides 7 Radiosurgery 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 Carmustine 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Sirolimus 5 Cilengitide 5 veliparib 4 veledimex 4 temsirolimus 4 selinexor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Glioblastoma × dostarlimab × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡